Among them, PSMA, EpCAM (epithelial cellular adhesion molecule), and MUC1 (mucin-1) are three representative targets for aptamer selection using the purified-protein-based SELEX, and for tumor-targeted delivery of aptamer-functionalized nanoparticles.215. This evidence concerns the gene MUC1 and neoplasm.